FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890825516> ?p ?o ?g. }

• W2890825516 abstract "The time to diagnosis of invasive Candida infection (ICI) is often too long to initiate timely antifungal therapy in patients with sepsis. Elevated serum (1,3)-β-D-glucan (BDG) concentrations have a high diagnostic sensitivity for detecting ICI. However, the clinical significance of elevated BDG concentrations is unclear in critically ill patients. The goal of this study is to investigate whether measurement of BDG in patients with sepsis and a high risk for ICI can be used to decrease the time to empiric antifungal therapy and thus, increase survival.This prospective multicenter open randomized controlled trial is being conducted in 19 German intensive care units. All adult patients with severe sepsis or septic shock and an increased risk for ICI are eligible for enrolment. Risk factors are total parenteral nutrition, previous abdominal surgery, previous antimicrobial therapy, and renal replacement therapy. Patients with proven ICI or those already treated with systemic antifungal substances are excluded. Patients are allocated to a BDG or standard care group. The standard care group receives targeted antifungal therapy as necessary. In the BDG group, BDG serum samples are taken after randomization and 24 h later. Antifungal therapy is initiated if BDG is ≥80 pg/ml in at least one sample. We plan to enroll 312 patients. The primary outcome is 28-day mortality. Other outcomes include antifungal-free survival within 28 days after enrolment, time to antifungal therapy, and the diagnostic performance of BDG compared to other laboratory tests for early ICI diagnosis. The statistical analysis will be performed according to the intent-to-treat principle.Because of the high risk of death, American guidelines recommend empiric antifungal therapy in sepsis patients with a high risk of ICI despite the limited evidence for such a recommendation. In contrast, empiric antifungal therapy is not recommended by European guidelines. BDG may offer a way out of this dilemma since BDG potentially identifies patients in need of early antifungals. However, the evidence for such an approach is inconclusive. This clinical study will generate solid evidence for health-care providers and authors of guidelines for the use of BDG in critically ill patients.Clinicaltrials.gov, NCT02734550 . Registered 12 April 2016." @default.
• W2890825516 created "2018-09-27" @default.
• W2890825516 creator A5021420921 @default.
• W2890825516 creator A5030902987 @default.
• W2890825516 creator A5044917199 @default.
• W2890825516 creator A5052526144 @default.
• W2890825516 creator A5069634818 @default.
• W2890825516 creator A5070655188 @default.
• W2890825516 creator A5085406499 @default.
• W2890825516 date "2018-09-04" @default.
• W2890825516 modified "2023-10-17" @default.
• W2890825516 title "(1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with sepsis and with an increased risk of invasive Candida infection (CandiSep): study protocol for a randomized controlled trial" @default.
• W2890825516 cites W1965625796 @default.
• W2890825516 cites W1992030675 @default.
• W2890825516 cites W2041927838 @default.
• W2890825516 cites W2054938569 @default.
• W2890825516 cites W2056554475 @default.
• W2890825516 cites W2056588441 @default.
• W2890825516 cites W2071756060 @default.
• W2890825516 cites W2074210146 @default.
• W2890825516 cites W2100572225 @default.
• W2890825516 cites W2100900594 @default.
• W2890825516 cites W2101821016 @default.
• W2890825516 cites W2103359253 @default.
• W2890825516 cites W2106858657 @default.
• W2890825516 cites W2108414743 @default.
• W2890825516 cites W2112046323 @default.
• W2890825516 cites W2113002556 @default.
• W2890825516 cites W2120644786 @default.
• W2890825516 cites W2123370987 @default.
• W2890825516 cites W2127508258 @default.
• W2890825516 cites W2135675030 @default.
• W2890825516 cites W2141171649 @default.
• W2890825516 cites W2146558016 @default.
• W2890825516 cites W2151254250 @default.
• W2890825516 cites W2151458427 @default.
• W2890825516 cites W2151578177 @default.
• W2890825516 cites W2157070947 @default.
• W2890825516 cites W2161872635 @default.
• W2890825516 cites W2163845781 @default.
• W2890825516 cites W2164001967 @default.
• W2890825516 cites W2166734004 @default.
• W2890825516 cites W2174070074 @default.
• W2890825516 cites W2177937039 @default.
• W2890825516 cites W2216117396 @default.
• W2890825516 cites W2260819425 @default.
• W2890825516 cites W2280404143 @default.
• W2890825516 cites W2282181907 @default.
• W2890825516 cites W2322839310 @default.
• W2890825516 cites W2342990795 @default.
• W2890825516 cites W2469192434 @default.
• W2890825516 cites W2481470067 @default.
• W2890825516 cites W2486218505 @default.
• W2890825516 cites W3016555942 @default.
• W2890825516 cites W3206071445 @default.
• W2890825516 doi "https://doi.org/10.1186/s13063-018-2868-0" @default.
• W2890825516 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6124015" @default.
• W2890825516 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30180873" @default.
• W2890825516 hasPublicationYear "2018" @default.
• W2890825516 type Work @default.
• W2890825516 sameAs 2890825516 @default.
• W2890825516 citedByCount "9" @default.
• W2890825516 countsByYear W28908255162019 @default.
• W2890825516 countsByYear W28908255162020 @default.
• W2890825516 countsByYear W28908255162022 @default.
• W2890825516 crossrefType "journal-article" @default.
• W2890825516 hasAuthorship W2890825516A5021420921 @default.
• W2890825516 hasAuthorship W2890825516A5030902987 @default.
• W2890825516 hasAuthorship W2890825516A5044917199 @default.
• W2890825516 hasAuthorship W2890825516A5052526144 @default.
• W2890825516 hasAuthorship W2890825516A5069634818 @default.
• W2890825516 hasAuthorship W2890825516A5070655188 @default.
• W2890825516 hasAuthorship W2890825516A5085406499 @default.
• W2890825516 hasBestOaLocation W28908255161 @default.
• W2890825516 hasConcept C126322002 @default.
• W2890825516 hasConcept C168563851 @default.
• W2890825516 hasConcept C177713679 @default.
• W2890825516 hasConcept C2776376669 @default.
• W2890825516 hasConcept C2777628635 @default.
• W2890825516 hasConcept C2778384902 @default.
• W2890825516 hasConcept C2779541074 @default.
• W2890825516 hasConcept C71924100 @default.
• W2890825516 hasConceptScore W2890825516C126322002 @default.
• W2890825516 hasConceptScore W2890825516C168563851 @default.
• W2890825516 hasConceptScore W2890825516C177713679 @default.
• W2890825516 hasConceptScore W2890825516C2776376669 @default.
• W2890825516 hasConceptScore W2890825516C2777628635 @default.
• W2890825516 hasConceptScore W2890825516C2778384902 @default.
• W2890825516 hasConceptScore W2890825516C2779541074 @default.
• W2890825516 hasConceptScore W2890825516C71924100 @default.
• W2890825516 hasFunder F4320321114 @default.
• W2890825516 hasIssue "1" @default.
• W2890825516 hasLocation W28908255161 @default.
• W2890825516 hasLocation W28908255162 @default.
• W2890825516 hasLocation W28908255163 @default.
• W2890825516 hasLocation W28908255164 @default.
• W2890825516 hasLocation W28908255165 @default.
• W2890825516 hasLocation W28908255166 @default.
• W2890825516 hasOpenAccess W2890825516 @default.
• W2890825516 hasPrimaryLocation W28908255161 @default.

• next